346 related articles for article (PubMed ID: 10224058)
1. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
Ramos-DeSimone N; Hahn-Dantona E; Sipley J; Nagase H; French DL; Quigley JP
J Biol Chem; 1999 May; 274(19):13066-76. PubMed ID: 10224058
[TBL] [Abstract][Full Text] [Related]
2. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
Hahn-Dantona E; Ramos-DeSimone N; Sipley J; Nagase H; French DL; Quigley JP
Ann N Y Acad Sci; 1999 Jun; 878():372-87. PubMed ID: 10415742
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
[TBL] [Abstract][Full Text] [Related]
4. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M; Chvyrkova I; Bernardo MM; Hernandez-Barrantes S; Fridman R
Biochem Biophys Res Commun; 2003 Aug; 308(2):386-95. PubMed ID: 12901881
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
[TBL] [Abstract][Full Text] [Related]
6. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
8. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
[TBL] [Abstract][Full Text] [Related]
9. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M
Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804
[TBL] [Abstract][Full Text] [Related]
10. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator.
Okumura Y; Sato H; Seiki M; Kido H
FEBS Lett; 1997 Feb; 402(2-3):181-4. PubMed ID: 9037191
[TBL] [Abstract][Full Text] [Related]
12. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
13. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
Itoh Y; Nagase H
J Biol Chem; 1995 Jul; 270(28):16518-21. PubMed ID: 7622455
[TBL] [Abstract][Full Text] [Related]
14. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
15. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.
HE CS; Wilhelm SM; Pentland AP; Marmer BL; Grant GA; Eisen AZ; Goldberg GI
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2632-6. PubMed ID: 2468156
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
[TBL] [Abstract][Full Text] [Related]
17. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
18. Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminogen activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1.
Hu B; Kapila YL; Buddhikot M; Shiga M; Kapila S
Matrix Biol; 2000 Dec; 19(7):657-69. PubMed ID: 11102755
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.
Farina AR; Coppa A; Tiberio A; Tacconelli A; Turco A; Colletta G; Gulino A; Mackay AR
Int J Cancer; 1998 Mar; 75(5):721-30. PubMed ID: 9495240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
